Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observationFootnote^†

^†Supported in part by the ‘Associazione Emofilia ed altre coagulopatie delle Tre Venezie’.

References

• Girolami A, Ferrari S, Sambado L, Peroni E, Cosi E. Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases. Clin Appl Thromb Hemost. 2015;21(4):359–64. doi: 10.1177/1076029614548056
   PubMed Web of Science ®Google Scholar
• Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia. 2006;12(4):345–51. Review. doi: 10.1111/j.1365-2516.2006.01299.x
   PubMed Web of Science ®Google Scholar
• Ruiz-Seaz A. Occurrence of thrombosis in rare bleeding disorders. Semin Thromb Hemost. 2013;39(6):684–92. doi: 10.1055/s-0033-1353391
   PubMed Web of Science ®Google Scholar
• Salomon O, Steinberg DM, Dardik R, Rosenberg N, Zivelin A, Tamarin I, et al. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost. 2003;1(4):658–61. doi: 10.1046/j.1538-7836.2003.00195.x
   PubMed Web of Science ®Google Scholar
• Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood. 2008;111(8):4113–7. doi: 10.1182/blood-2007-10-120139
   PubMed Web of Science ®Google Scholar
• Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost. 2011;105(2):269–73. doi: 10.1160/TH10-05-0307
   PubMed Web of Science ®Google Scholar
• Girolami A, Bertozzi I, de Marinis GB, Tasinato V, Sambado L. Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B. J Thromb Thrombolysis. 2014;37(3):293–7. doi: 10.1007/s11239-013-0943-7
   PubMed Web of Science ®Google Scholar
• Girolami A, Candeo N, De Marinis GB, Bonamigo E, Girolami B. Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation. J Thromb Thrombolysis. 2011;31(1):57–63. doi: 10.1007/s11239-010-0495-z
   PubMed Web of Science ®Google Scholar
• Girolami A, Candeo N, Vettore S, Lombardi AM, Girolami B. The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency. J Thromb Thrombolysis. 2010;29(3):299–302. doi: 10.1007/s11239-009-0342-2
   PubMed Web of Science ®Google Scholar
• Girolami A, Ferrari S, Sambado L, Peroni E, Cosi E. Myocardial infarction and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases. Clin Appl Thromb Hemost. 2015;21(4):359–64. doi: 10.1177/1076029614548056
   PubMed Web of Science ®Google Scholar
• Humphries JE, Schlein AE, Sarembock IJ, Gonias SL. Myocardial infarction in a patient with factor XI deficiency and a lupus anticoagulant. Eur Heart J. 1991;12(9):1045–7.
   PubMed Web of Science ®Google Scholar
• Sherer Y, Bar-Zohar D, Levy Y, Shoenfeld Y. Thromboembolic phenomena in patients with hereditary factor XI deficiency. Ann Med Interne (Paris). 1998;149(8):492–4.
   PubMedGoogle Scholar
• Brunken R, Follette D, Wittig J. Coronary artery bypass in hereditary factor XI deficiency. Ann Thorac Surg. 1984;38(4):406–8. doi: 10.1016/S0003-4975(10)62296-5
   PubMed Web of Science ®Google Scholar
• Mungee S, Lapin R, Cavusoglu E, Clark LT, Marmur JD. Percutaneous coronary intervention in a patient with congenital factor XI deficiency and acquired inhibitor. Cardiology. 2007;107(1):69–72. doi: 10.1159/000094077
   PubMed Web of Science ®Google Scholar
• Shimony A, Levi E, Zahger D. Percutaneous coronary intervention in a patient with factor XI deficiency. J Invasive Cardiol. 2009;21(9):E178–9.
   PubMedGoogle Scholar
• Bolton-Maggs P, Goudemand J, Hermans C, Makris M, de Moerloose P. FXI concentrate use and risk of thrombosis. Haemophilia. 2014;20(4):e349–51. doi: 10.1111/hae.12457
   PubMed Web of Science ®Google Scholar
• Clyne LP, Farle LR, Chopyk RL. Procainamide induced circulating anticoagulants in a congenitally-deficient factor XI patient. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(2):239–44.
   PubMedGoogle Scholar
• Ip HL, Chan AY, Ng KC, Soo YO, Wong LK. Case report: a 70-year-old man with undiagnosed factor VII deficiency presented with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22(8):e664–6. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.035
   PubMed Web of Science ®Google Scholar
• Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B. Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis. 2010;30(2):172–8. doi: 10.1007/s11239-009-0435-y
   PubMed Web of Science ®Google Scholar
• Girolami A, Berti de Marinis G, Bertozzi I, Peroni E, Tasinato V, Lombardi AM. Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency. Eur J Haematol. 2013;91(2):152–6. doi: 10.1111/ejh.12129
   PubMed Web of Science ®Google Scholar
• Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342(10):696–701. doi: 10.1056/NEJM200003093421004
   PubMed Web of Science ®Google Scholar
• Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. N Engl J Med. 2015 Jan 15;372(3):232–40. doi: 10.1056/NEJMoa1405760
   PubMed Web of Science ®Google Scholar
• Cushman M, O'Meara ES, Folsom AR, Heckbert SR. Coagulation factors IX through XIII and the risk of future venous thrombosis: the longitudinal investigation of thromboembolism etiology. Blood. 2009;114(14):2878–83. doi: 10.1182/blood-2009-05-219915
   PubMed Web of Science ®Google Scholar
• Matafonov A, Cheng Q, Geng Y, Verhamme IM, Umunakwe O, Tucker EI, et al. Evidence for factor IX-independent roles for factor XIa in blood coagulation. J Thromb Haemost. 2013;11(12):2118–27. doi: 10.1111/jth.12435
   PubMed Web of Science ®Google Scholar
• Löwenberg EC, Meijers JC, Monia BP, Levi M. Coagulation factor XI as a novel target for antithrombotic treatment. J Thromb Haemost. 2010;8(11):2349–57. doi: 10.1111/j.1538-7836.2010.04031.x
   PubMed Web of Science ®Google Scholar
• Girolami A, Ferrari S, Cosi E, Sambado L, Girolami B. Prevalence of hypertension and its complications in congenital prekallikrein deficiency: analysis of all reported cases and clinical significance. Blood Coagul Fibrinolysis. 2015;26(5):560–3. doi: 10.1097/MBC.0000000000000294
   PubMed Web of Science ®Google Scholar
• Girolami A, Marun S, Vettore S, Scaliter G, Molina A, Scarparo P, et al. A large family from Argentina with prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): prekallikrein Cordoba. Am J Hematol. 2010;85(5):363–6.
   PubMed Web of Science ®Google Scholar
• Girolami A, Sambado L, Lombardi AM. The impact of blood coagulability on atherosclerosis and cardiovascular disease. J Thromb Haemost. 2013;11:213–4. doi: 10.1111/jth.12030
   PubMed Web of Science ®Google Scholar